Lutetium-177Lu BL-ARC001

BL-ARC001 · Sichuan Baili Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Lutetium-177Lu BL-ARC001, covering 2026-01-06 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Lutetium [177Lu] BL-ARC001 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors [Phase 1]

See pricing